Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remington

Showing results (221-230 of 2,716) with videos related to

Pageof 272
Sort By:
The Journal of Clinical Psychiatry|May 26, 1999
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PETG Remington, S Kapur
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
SB-277011 GlaxoSmithKlineG Remington, S Kapur
Evidence-Based Mental Health|August 16, 2002
Review: amisulpride is effective and safe for schizophreniaGary Remington, Shitij Kapur
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 6, 2001
Electroconvulsive therapy in cases of treatment-resistant psychosisV Parker, G Remington
Biological Psychiatry|December 18, 2001
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficientS Kapur, G Remington
Journal of Clinical Psychopharmacology|October 1, 1994
Risperidone and obsessive-compulsive symptomsG Remington, M Adams
Perception & Psychophysics|April 1, 1984
Moving attention: evidence for time-invariant shifts of visual selective attentionR Remington, L Pierce
The American Journal of Psychiatry|October 1, 1984
Case report of de Clerembault syndrome, bipolar affective disorder, and response to lithiumG Remington, H Book
Schizophrenia Bulletin|July 23, 2008
Negative symptoms in schizophrenia: avolition and Occam's razorGeorge Foussias, Gary Remington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 8, 2010
Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-makingGeorge Foussias, Gary Remington
Pageof 272

Showing results (221-230 of 2,716) with videos related to

Sort By:
Pageof 272
The Journal of Clinical Psychiatry|May 26, 1999
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PETG Remington, S Kapur
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
SB-277011 GlaxoSmithKlineG Remington, S Kapur
Evidence-Based Mental Health|August 16, 2002
Review: amisulpride is effective and safe for schizophreniaGary Remington, Shitij Kapur
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 6, 2001
Electroconvulsive therapy in cases of treatment-resistant psychosisV Parker, G Remington
Biological Psychiatry|December 18, 2001
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficientS Kapur, G Remington
Journal of Clinical Psychopharmacology|October 1, 1994
Risperidone and obsessive-compulsive symptomsG Remington, M Adams
Perception & Psychophysics|April 1, 1984
Moving attention: evidence for time-invariant shifts of visual selective attentionR Remington, L Pierce
The American Journal of Psychiatry|October 1, 1984
Case report of de Clerembault syndrome, bipolar affective disorder, and response to lithiumG Remington, H Book
Schizophrenia Bulletin|July 23, 2008
Negative symptoms in schizophrenia: avolition and Occam's razorGeorge Foussias, Gary Remington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 8, 2010
Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-makingGeorge Foussias, Gary Remington
Pageof 272